United Therapeutics's total assets for Q4 2023 were $7.17B, an increase of 2.04% from the previous quarter. UTHR total liabilities were $1.18B for the fiscal quarter, a -9.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.